[go: up one dir, main page]

FR2603040B1 - Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose - Google Patents

Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose

Info

Publication number
FR2603040B1
FR2603040B1 FR8611986A FR8611986A FR2603040B1 FR 2603040 B1 FR2603040 B1 FR 2603040B1 FR 8611986 A FR8611986 A FR 8611986A FR 8611986 A FR8611986 A FR 8611986A FR 2603040 B1 FR2603040 B1 FR 2603040B1
Authority
FR
France
Prior art keywords
schistosomosis
poxviruses
protein
prevention
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8611986A
Other languages
English (en)
Other versions
FR2603040A1 (fr
Inventor
Paul Sondermeyer
Jean-Marc Balloul
Raymond Pierce
Jean-Marie Grzych
Marie-Paule Kieny
Gerard Loison
Andre Capron
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8611986A priority Critical patent/FR2603040B1/fr
Priority to AU77170/87A priority patent/AU613583B2/en
Priority to EP87401915A priority patent/EP0268501B1/fr
Priority to ES87401915T priority patent/ES2061521T3/es
Priority to CA000545007A priority patent/CA1340839C/fr
Priority to DE3788852T priority patent/DE3788852T2/de
Priority to AT87401915T priority patent/ATE100493T1/de
Priority to PH35714A priority patent/PH31198A/en
Priority to JP62209104A priority patent/JP3127261B2/ja
Priority to DK198704380A priority patent/DK173779B1/da
Priority to KR870009208A priority patent/KR880002894A/ko
Priority to CN198787106696A priority patent/CN87106696A/zh
Publication of FR2603040A1 publication Critical patent/FR2603040A1/fr
Application granted granted Critical
Publication of FR2603040B1 publication Critical patent/FR2603040B1/fr
Priority to US07/964,471 priority patent/US5597570A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8611986A 1986-08-22 1986-08-22 Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose Expired - Fee Related FR2603040B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR8611986A FR2603040B1 (fr) 1986-08-22 1986-08-22 Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose
AU77170/87A AU613583B2 (en) 1986-08-22 1987-08-18 Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
ES87401915T ES2061521T3 (es) 1986-08-22 1987-08-20 Proteinas con actividad glutation-s-transferasa, secuencias de adn, anticuerpos, poxvirus y medicamentos para la prevencion de la equistosomiasis.
CA000545007A CA1340839C (fr) 1986-08-22 1987-08-20 Proteines et leurs procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees, compositions pharmaceutiques utiles dans la prevention de la schistosomose et applications a titre d'agent presentant une activite glutathion-s-transferase
DE3788852T DE3788852T2 (de) 1986-08-22 1987-08-20 Proteine mit Glutathion-S-Transferase-Aktivität, DNA-Sequenzen, Antikörper, Poxviren und Arzneimittel zur Prävention von Schistosomiasis.
AT87401915T ATE100493T1 (de) 1986-08-22 1987-08-20 Proteine mit glutathion-s-transferase-aktivitaet, dna-sequenzen, antikoerper, poxviren und arzneimittel zur praevention von schistosomiasis.
EP87401915A EP0268501B1 (fr) 1986-08-22 1987-08-20 Protéines à activité glutathion-S-transférase, séquences d'ADN, anticorps, poxvirus et médicaments pour la prévention de la schistosomose
JP62209104A JP3127261B2 (ja) 1986-08-22 1987-08-21 蛋白質及びその製法、ｄｎａ配列、抗体及びその用途、ポックスウイルス、形質転換又は感染された細胞、住血吸虫症予防剤及びグルタチオン ｓ−トランスフェラーゼ活性薬剤としての用途
PH35714A PH31198A (en) 1986-08-22 1987-08-21 Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
DK198704380A DK173779B1 (da) 1986-08-22 1987-08-21 Schistosomprotein, DNA-fragment kodende for proteinet, ekspressionsenhed og viral vektor indeholdende DNA-fragmentet, celle transformeret med ekspressionsenheden, farmaceutisk præparat indeholdende proteinet eller vektoren, anvendelse af proteinet
KR870009208A KR880002894A (ko) 1986-08-22 1987-08-22 주혈흡충증왁진으로 사용되는 단백질과 dna 시퀀스
CN198787106696A CN87106696A (zh) 1986-08-22 1987-08-22 蛋白质及其制备方法，adn的顺序，抗体及其用途，痘病病毒，被转化或感染的细胞用于预防血吸虫病的药剂组合物，以及作为谷胱甘肽-s-转移酶活性的显示剂的用途
US07/964,471 US5597570A (en) 1986-08-22 1992-10-21 Protein recognized by antibodies raised against native P28 of schistosoma mansoni

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611986A FR2603040B1 (fr) 1986-08-22 1986-08-22 Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose

Publications (2)

Publication Number Publication Date
FR2603040A1 FR2603040A1 (fr) 1988-02-26
FR2603040B1 true FR2603040B1 (fr) 1990-01-26

Family

ID=9338458

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8611986A Expired - Fee Related FR2603040B1 (fr) 1986-08-22 1986-08-22 Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose

Country Status (1)

Country Link
FR (1) FR2603040B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052011C (zh) * 1994-05-12 2000-05-03 北京医科大学 血吸虫疫苗肽
CA2249007A1 (fr) * 1996-03-14 1997-09-18 Takeshi Shibuya Proteine anti-inflammatoire immunomodulatrice derivee d'un parasite
CN101676389A (zh) 2000-11-23 2010-03-24 巴法里安诺迪克有限公司 改良安卡拉痘苗病毒变体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002077A1 (fr) * 1982-11-30 1984-06-07 Us Health Procede de production de recombinants du virus de la variole pour l'expression de genes etrangers

Also Published As

Publication number Publication date
FR2603040A1 (fr) 1988-02-26

Similar Documents

Publication Publication Date Title
MA20878A1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
BE902750A (fr) Nouveaux derives de ganglioside.
PT82575B (fr) Procede de preparation d'un produit conjugue constitue d'une adhesine de s.mutans de nature proteique d'une composition a activite immunogene et d'un polysaccharide de s.mutans et son utilisation notamment dans des vaccins anti-caries
IT1238348B (it) Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
FR2598420B1 (fr) Nouveaux esters retinoiques d'antibiotiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
FR2553409B1 (fr) Nouveaux benzenesulfonyl-lactames, leur procede de preparation et leur application comme substance active de compositions pharmaceutiques
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
FR2625099B1 (fr) Proteines et leur procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees et compositions pharmaceutiques utiles dans la prevention de la toxoplasmose
FR2603040B1 (fr) Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose
IT8919050A0 (it) Procedimento per la introduzione di dna esogeno nelle cellule somatiche e germinali di animali.
FR2573077B1 (fr) Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant
FR2598591B1 (fr) Procede de culture des procaryoyes et eucaryotes et utilisation des cellules ainsi preparees dans les compositions cosmetiques, alimentaires et des supplements au fourrage
FR2631829B1 (fr) Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
FR2582835B1 (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2636630B1 (fr) Nouveaux composes benzofuranniques, leur procede de preparation, compositions pharmaceutiques et cosmetique les contenant et utilisation de ces compositions
BE1002121A4 (fr) Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation et medicaments les contenant.
FR2595697B1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
FR2611497B1 (fr) Agglomerats, leur preparation et compositions pharmaceutiques et/ou cosmetiques les contenant
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
FR2595703B1 (fr) Nouveaux phospholipides, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2592043B1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2621912B1 (fr) Nouveaux derives du norbornane, leur procede de preparation et compositions cosmetique et medicamenteuse les contenant
FR2599738B1 (fr) Nouveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique, leur procede de preparation, leur application comme medcaments et les compositions les renfermant
PT82853A (fr) Procede de preparation de nouveaux benzamides et des compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse